IRIDEX Profit Margin 2012-2026 | IRIX

Current and historical gross margin, operating margin and net profit margin for IRIDEX (IRIX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. IRIDEX net profit margin as of March 31, 2026 is -8.42%.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Sector Industry Market Cap Revenue
Computer and Technology Laser Systems and Components $0.017B $0.053B
IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.
Stock Name Country Market Cap PE Ratio
IPG Photonics (IPGP) United States $5.404B 89.66
Applied Energetics (AERG) United States $0.246B 0.00